NCT07666841

Brief Summary

Pulmonary rehabilitation is a key treatment for lung diseases, but many patients struggle to attend sessions due to travel distances, physical limitations, or logistical barriers. The purpose of this study is to evaluate whether a tele-pulmonary rehabilitation (TPR) program can improve the rates of treatment initiation and adherence among patients with chronic lung diseases compared to traditional, center-based pulmonary rehabilitation. Additionally, the study will assess improvements in quality of life, physical symptoms, and safety in both groups. This study will enroll 90 patients from two medical centers in Israel (Tel Aviv and Barzilai). Participants will be randomly assigned to one of two groups:

  1. 1.The control group will receive usual care with a referral by a pulmonologist to standard pulmonary rehabilitation at a medical center.
  2. 2.The intervention group will participate in a supervised remote tele-rehabilitation program using a dedicated application and remote monitoring.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
29mo left

Started Jul 2026

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress3%
Jul 2026Dec 2028

First Submitted

Initial submission to the registry

June 18, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 24, 2026

Completed
7 days until next milestone

Study Start

First participant enrolled

July 1, 2026

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2028

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

June 24, 2026

Status Verified

June 1, 2026

Enrollment Period

2 years

First QC Date

June 18, 2026

Last Update Submit

June 18, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Adherence to pulmonary rehabilitation Between the Study Groups

    Adherence will be defined as initiation of pulmonary rehabilitation in 3 months from study inclusion and completion of at least 50% (12 sessions) of the program (regular/remote based on allocation) within 6 months from inclusion.

    Assessed by a clinical research coordinator from enrollment to 6 months following study initiation.

Secondary Outcomes (16)

  • Safety of Tele-pulmonary Rehabilitation / Traditional Pulmonary Rehabilitation

    Assessed from enrollment to 6 months following study initiation.

  • Tele-pulmonary Rehabilitation / Traditional Pulmonary Rehabilitation Initiation Rate

    Assessed by a clinical research coordinator from enrollment to 6 months following study initiation.

  • Global Evaluation of Treatment Effectiveness (GETE) score

    Will be asked by the clinical research coordinator via phone call after 6 months following study initiation.

  • Respiratory Symptoms Burden Assessed by CAAT

    Assessed by a physician at baseline, and subsequent by the clinical research coordinator via phone call after 6 months following study initiation.

  • Health Care Utilization

    Assessed by a physician at baseline, and subsequent by the clinical research coordinator via phone call after 6 months following study initiation.

  • +11 more secondary outcomes

Study Arms (2)

Control

NO INTERVENTION

Participants in the control group will be sent back to their referring physicians with a recommendation to initiate pulmonary rehabilitation as soon as possible, signed by a pulmonologist. The treating physicians will also be notified.

Tele-Rehabilitation

EXPERIMENTAL

Participants will undergo a 12 weeks tele-rehabilitation program using a dedicated application. The intervention consists of 24 online sessions (twice weekly) led by a senior respiratory physiotherapist in groups of up to 5 participants.

Other: Tele-Rehabilitation

Interventions

Participants will undergo a 12 weeks tele-rehabilitation program using a dedicated application. The intervention consists of 24 online sessions (twice weekly) led by a senior respiratory physiotherapist in groups of up to 5 participants. The sessions include: 1. Supervised Exercise: Aerobic and resistance training using household items, stretching, and breathing techniques. 2. Remote Monitoring: Vital signs (heart rate and oxygen saturation) monitored every 10-15 minutes via a study-provided pulse oximeter. 3. Comprehensive Education: Guidance on lifestyle, nutrition, and physical activity. 4. Digital Support: The app provides activity tracking, symptom logging, session reminders, and guided home exercises. At the end of each session, every participant receives a personalized exercise plan based on their performance and preferences, which is displayed in the app.

Also known as: Tele-Pulmonary Rehabilitation
Tele-Rehabilitation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients meeting the Israeli Health Basket criteria for reimbursement of pulmonary rehabilitation (PR), including one of the following conditions:
  • COPD with an FEV1 below 50% or with severe exacerbation (hospitalization) in the previous year or two moderate exacerbations in the previous year.
  • Interstitial lung disease with an FVC below 80% or a DLCO below 60%.
  • Bronchiectasis with at least two exacerbations in the past year or at least one hospitalization, and an FEV1 below 80%.
  • Pulmonary arterial hypertension.
  • Willingness to initiate a PR or Tele-PR (TPR) programs.
  • Ability to perform the TPR program or traditional PR activities as assessed by a member of the study team prior to enrollment.
  • Agree to participate, with signed informed consent.

You may not qualify if:

  • Uncontrolled comorbidity (e.g uncontrolled congestive heart failure)
  • Inability to operate the mobile application.
  • Without a mobile device or computer.
  • A hospitalization in the 2-months prior to randomization.
  • Completed PR program in the last 12 months.
  • Inability to complete 10 repetitions in the 1-minute sit-to-stand test or 5-second single-leg stance
  • Pregnancy
  • Inability to provide informed consent due to impaired decision-making capacity, as determined by the study's capacity assessment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Barzilai Medical Center

Ashkelon, Israel

Location

Tel Aviv Sourasky Medical Center

Tel Aviv, 6423906, Israel

Location

Related Links

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructivePulmonary Arterial HypertensionLung Diseases, Interstitial

Interventions

Telerehabilitation

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsHypertension, Pulmonary

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and ServicesTelemedicineDelivery of Health CarePatient Care ManagementHealth Services Administration

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
All outcomes will be assessed at similar time frames for both the intervention and control groups and filled in an identical form. All phone calls to assess the study outcomes will be performed by research assistances blinded to group allocation. All forms from each phone call will be stored in a single sealed box without details on group allocation. The data extraction from the forms for the study database will be performed at the end of the study by research assistants who will be blinded to group allocation. Statistical analysis will also be done by masking group allocation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 18, 2026

First Posted

June 24, 2026

Study Start

July 1, 2026

Primary Completion (Estimated)

July 1, 2028

Study Completion (Estimated)

December 31, 2028

Last Updated

June 24, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Locations